Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
4.87 Down 0.27(5.25%) Feb 27, 4:00PM EST
Add to Portfolio
Prev Close:5.14
Open:5.15
Bid:3.13 x 600
Ask:5.20 x 200
1y Target Est:7.00
Beta:2.64
Next Earnings Date:N/A
Day's Range:4.87 - 5.18
52wk Range:1.94 - 6.87
Volume:4,556,764
Avg Vol (3m):2,457,020
Market Cap:417.89M
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRADown 5.25%417.89M
DVAXUp 0.57%462.76M
PFEDown 0.78%216.24B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5,880.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Dec-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback